Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06842771 · ClinicalTrials.gov registry record · Phase 4
Pain with Differing Intraperitoneal Washes At the End of Laparoscopic Gynecologic Surgery
A Phase 4 study, sponsored by University of Tennessee.
- Not yet
- Registry status
- Phase 4
- Development phase
- 96
- Enrollment target
NCT06842771 is a Phase 4 study that has not yet begun recruiting, run by University of Tennessee. The registered enrollment target is 96 participants.
The verdict
NCT06842771, a Phase 4 study, has not yet begun recruiting, sponsored by University of Tennessee.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 96 participants
- Enrollment target
Study Summary
We hypothesize that instilling intraperitoneal Marcaine (without epinephrine) at the end of a non-total laparoscopic gynecologic surgery (adnexa only, which includes the ovaries, fallopian tubes, and associated ligaments, vessels, and connective tissue) will result in less pain and reduced opioid use postoperatively.
Interventions
- OTHER Normal Saline (0.9% NaCl)
- DRUG Marcaine hydrochloride without epinephrine 0.5%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2025-03 |
| Est. Completion | 2027-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06842771
The ClinicalTrials.gov registry entry for NCT06842771 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal Saline (0.9% NaCl) is the first listed.
NCT06842771 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06842771 about?
NCT06842771 is a clinical study titled "Pain with Differing Intraperitoneal Washes At the End of Laparoscopic Gynecologic Surgery". We hypothesize that instilling intraperitoneal Marcaine (without epinephrine) at the end of a non-total laparoscopic gynecologic surgery (adnexa only, which includes the ovaries, fallopian tubes, and associated ligaments, vessels, and connective tissue) will result in less pain and reduced opioid us...
What is the current status of trial NCT06842771?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 96 participants. The study started on 2025-03. Estimated completion is 2027-03.
What interventions are being tested in trial NCT06842771?
The interventions under investigation include: Normal Saline (0.9% NaCl) (OTHER), Marcaine hydrochloride without epinephrine 0.5% (DRUG).
Who is sponsoring clinical trial NCT06842771?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.